Free Trial

So-Young International (NASDAQ:SY) Upgraded at Citigroup

So-Young International logo with Medical background

So-Young International (NASDAQ:SY - Get Free Report) was upgraded by research analysts at Citigroup from a "neutral" rating to a "buy" rating in a report released on Tuesday, MarketBeat Ratings reports. The firm presently has a $5.50 price objective on the stock. Citigroup's price target indicates a potential upside of 43.23% from the company's current price.

So-Young International Stock Up 0.3%

Shares of NASDAQ:SY opened at $3.84 on Tuesday. The company's 50 day moving average price is $13.03 and its two-hundred day moving average price is $13.17. So-Young International has a 12-month low of $0.66 and a 12-month high of $4.84. The firm has a market cap of $389.53 million, a PE ratio of -4.80 and a beta of 1.72.

So-Young International (NASDAQ:SY - Get Free Report) last issued its earnings results on Friday, May 16th. The company reported ($0.60) earnings per share for the quarter, beating analysts' consensus estimates of ($5.10) by $4.50. So-Young International had a negative net margin of 41.03% and a negative return on equity of 2.14%. The firm had revenue of $40.95 million for the quarter, compared to analyst estimates of $293.76 million.

Hedge Funds Weigh In On So-Young International

An institutional investor recently raised its position in So-Young International stock. Jane Street Group LLC raised its stake in So-Young International Inc. Sponsored ADR (NASDAQ:SY - Free Report) by 264.2% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 36,419 shares of the company's stock after purchasing an additional 26,419 shares during the period. Jane Street Group LLC's holdings in So-Young International were worth $30,000 as of its most recent SEC filing. 35.31% of the stock is owned by institutional investors.

So-Young International Company Profile

(Get Free Report)

So-Young International Inc operates an online platform for consumption healthcare services in the People's Republic of China. The company offers So-Young Mobile App that offers users medical aesthetic knowledge and experience to reach an informed medical aesthetic treatment decision and make reservations for treatment with medical professionals and medical aesthetic institutions; So-Young Beauty which provides similar interfaces and functions as the mobile app, as well as serves as additional access points to the platform; and medical aesthetic community content through its website soyoung.com.

Read More

Should You Invest $1,000 in So-Young International Right Now?

Before you consider So-Young International, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and So-Young International wasn't on the list.

While So-Young International currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in August 2025
The $2.5B Merger No One Is Talking About
ALERT: Big Tech Earnings – Watch Before Wednesday

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines